Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan.

Kamijo, Hiroshi; Mochizuki, Katsunori; Nakamura, Yuta; Mori, Kotaro; Ichikawa, Michitaro; Nitta, Kenichi; Imamura, Hiroshi

Kamijo, Hiroshi; Mochizuki, Katsunori; Nakamura, Yuta; Mori, Kotaro; Ichikawa, Michitaro; Nitta, Kenichi; Imamura, Hiroshi.

Afiliação

Kamijo H; Department of Emergency and Critical Care Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
Mochizuki K; Department of Emergency and Critical Care Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
Nakamura Y; Department of Emergency Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami Minami-ku, Kumamoto 861-4193, Japan.
Mori K; Department of Emergency and Critical Care Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
Ichikawa M; Department of Emergency and Critical Care Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
Nitta K; Department of Emergency and Critical Care Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
Imamura H; Department of Emergency and Critical Care Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.

J Clin Med ; 9(8)2020 Aug 13.

Article em En | MEDLINE | ID: mdl-32823637

Palavras-chave

anticoagulant; blood purification; nafamostat mesylate; sepsis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google